These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36064715)

  • 1. ZMYND8 suppresses MAPT213 LncRNA transcription to promote neuronal differentiation.
    Adhikary S; Singh V; Choudhari R; Yang B; Adhikari S; Ramos EI; Chaudhuri S; Roy S; Gadad SS; Das C
    Cell Death Dis; 2022 Sep; 13(9):766. PubMed ID: 36064715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8.
    Adhikary S; Sanyal S; Basu M; Sengupta I; Sen S; Srivastava DK; Roy S; Das C
    J Biol Chem; 2016 Feb; 291(6):2664-81. PubMed ID: 26655721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZMYND8 Is a Regulator of Sonic Hedgehog Signaling in ATRA-Mediated Differentiation of Neuroblastoma Cells.
    Guha D; Singh V; Nandi S; Ramos EI; Gadad SS; Das C
    Biochemistry; 2024 Jun; 63(12):1534-1542. PubMed ID: 38804064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation.
    Basu M; Khan MW; Chakrabarti P; Das C
    Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):450-459. PubMed ID: 28232094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
    Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
    Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ZMYND8 to Treat Cancer.
    Chen Y; Tsai YH; Tseng SH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
    Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
    Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.
    Cao Z; Budinich KA; Huang H; Ren D; Lu B; Zhang Z; Chen Q; Zhou Y; Huang YH; Alikarami F; Kingsley MC; Lenard AK; Wakabayashi A; Khandros E; Bailis W; Qi J; Carroll MP; Blobel GA; Faryabi RB; Bernt KM; Berger SL; Shi J
    Mol Cell; 2021 Sep; 81(17):3604-3622.e10. PubMed ID: 34358447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.
    Carney SV; Banerjee K; Mujeeb A; Zhu B; Haase S; Varela ML; Kadiyala P; Tronrud CE; Zhu Z; Mukherji D; Gorla P; Sun Y; Tagett R; Núñez FJ; Luo M; Luo W; Ljungman M; Liu Y; Xia Z; Schwendeman A; Qin T; Sartor MA; Costello JF; Cahill DP; Lowenstein PR; Castro MG
    Clin Cancer Res; 2023 May; 29(9):1763-1782. PubMed ID: 36692427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.
    Gong F; Chiu LY; Cox B; Aymard F; Clouaire T; Leung JW; Cammarata M; Perez M; Agarwal P; Brodbelt JS; Legube G; Miller KM
    Genes Dev; 2015 Jan; 29(2):197-211. PubMed ID: 25593309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination.
    Delgado-Benito V; Rosen DB; Wang Q; Gazumyan A; Pai JA; Oliveira TY; Sundaravinayagam D; Zhang W; Andreani M; Keller L; Kieffer-Kwon KR; Pękowska A; Jung S; Driesner M; Subbotin RI; Casellas R; Chait BT; Nussenzweig MC; Di Virgilio M
    Mol Cell; 2018 Nov; 72(4):636-649.e8. PubMed ID: 30293785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
    Choi S; Lee KW; Koh HH; Park S; Yeo SY; Joh JW; Choi MS; Kim SH; Park CK; Ha SY
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3517-3534. PubMed ID: 34462784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb Complex.
    Ghosh K; Tang M; Kumari N; Nandy A; Basu S; Mall DP; Rai K; Biswas D
    Cell Rep; 2018 Aug; 24(8):2141-2154.e6. PubMed ID: 30134174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of tumor suppressor ZMYND8 in inducing differentiation of breast cancer cells through its dual-histone binding function.
    Mukherjee S; Sen S; Adhikary S; Sengupta A; Mandal P; Dasgupta D; Chakrabarti P; Roy S; DAS C
    J Biosci; 2020; 45():. PubMed ID: 31965980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA HOTAIR regulates myeloid differentiation through the upregulation of p21 via miR-17-5p in acute myeloid leukaemia.
    Hu L; Liu J; Meng Y; Zheng H; Ding C; Wang H; Charwudzi A; Li M; Li J; Zhai Z; Xiong S
    RNA Biol; 2021 Oct; 18(10):1434-1444. PubMed ID: 33241756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage.
    Spruijt CG; Luijsterburg MS; Menafra R; Lindeboom RG; Jansen PW; Edupuganti RR; Baltissen MP; Wiegant WW; Voelker-Albert MC; Matarese F; Mensinga A; Poser I; Vos HR; Stunnenberg HG; van Attikum H; Vermeulen M
    Cell Rep; 2016 Oct; 17(3):783-798. PubMed ID: 27732854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
    Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
    Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer.
    Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion.
    Tang K; Yin T; Deng B; Wang M; Ren Z; Wang S; Liu X; Li H; Wang J; Du Y; Zhou J; Chen Y; Wang Y
    J Biol Chem; 2024 Aug; 300(9):107672. PubMed ID: 39128723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.